Limited Competition: Outcomes of Electronic Medical Records and Genomics (eMERGE) Genomic Risk Assessment and Management Network - Clinical Sites (U01, Clinical Trial Required)
ID: 359172Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/359172
Timeline
    Description

    The National Institutes of Health (NIH) is announcing a limited competition funding opportunity titled "Outcomes of Electronic Medical Records and Genomics (eMERGE) Genomic Risk Assessment and Management Network - Clinical Sites (U01, Clinical Trial Required)." This initiative aims to extend the follow-up and collection of outcome data for 25,000 participants involved in genomically informed risk assessment and management recommendations within the eMERGE Network, focusing on adherence to preventative recommendations and identifying correlates of adherence across various demographics. The total estimated funding for this program is $5.8 million, with approximately 10 awards expected to be made, and applications are anticipated to be due in late 2025, with project start dates projected for July 1, 2026. Interested applicants, specifically those funded under RFA-HG-19-013 and RFA-HG-19-014, can reach out to Robb Rowley, MD, at Robb.Rowley@nih.gov or by phone at 301-827-9126 for further information.

    Point(s) of Contact
    Robb Rowley, MD National Human Genome Research Institute
    (301) 827-9126
    Robb.Rowley@nih.gov
    Files
    No associated files provided.
    Similar Opportunities
    Single Source: Outcomes of Electronic Medical Records and Genomics (eMERGE) Genomic Risk Assessment and Management Network - Coordinating Center (U01 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is seeking a coordinating center for the Outcomes of Electronic Medical Records and Genomics (eMERGE) Genomic Risk Assessment and Management Network through a single-source funding opportunity. This initiative aims to extend the follow-up and collection of outcome data for 25,000 participants who have received genomically informed risk assessment and management recommendations, with a focus on assessing adherence to preventative recommendations and identifying correlates of adherence across various demographics. The total estimated funding for this cooperative agreement is $1,200,000, with the application expected to be due in 2025 and the project anticipated to start on July 1, 2026. Interested applicants, specifically the Principal Investigators associated with the award issued under RFA-HG-19-015 to Vanderbilt University Medical Center, can reach out to Robb Rowley, MD, at Robb.Rowley@nih.gov or by phone at 301-827-9126 for further information.
    Clinical Data Ecosystem for Genomics (CDEG)
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) for the Clinical Data Ecosystem for Genomics (CDEG), aimed at establishing a network to enhance the integration and sharing of genomic sequencing data among healthcare providers, labs, and patients. The initiative seeks to reduce barriers to clinical data sharing by creating a pilot ecosystem that demonstrates best practices, developing standardized APIs, and producing open-source clinical software applications that facilitate access to genomic data across various healthcare settings. This cooperative agreement is particularly relevant for small businesses with expertise in genomic medicine, data science, and health information exchange, and interested applicants are encouraged to begin forming collaborations in anticipation of the application process. For further inquiries, potential applicants can contact Jennifer Troyer at jennifer.troyer@nih.gov or by phone at 301-312-3276. The estimated synopsis post date is December 1, 2025, with applications expected to close by March 2, 2026, and awards anticipated by October 30, 2026.
    Centers of Excellence in Genomic Science (CEGS)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the Centers of Excellence in Genomic Science (CEGS) program, aimed at fostering interdisciplinary research teams to tackle significant biomedical challenges from a genomics perspective. The initiative seeks to develop innovative concepts, methods, and technologies that can lead to transformative advancements in genomic science, genomic medicine, and computational genomics, with a focus on high-risk, high-reward projects that are unlikely to be pursued through standard funding mechanisms. With an estimated total program funding of $5 million and the expectation of awarding two grants, interested applicants can reach out to Stephanie A. Morris at morriss2@mail.nih.gov or call 301-435-5738 for further information. The application process is set to open with a synopsis posting on March 25, 2026, and will close on June 24, 2026, with awards anticipated by April 1, 2027.
    GREGoRi Data Coordination and Outreach Center (U01, Clinical Trials Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for the establishment of the GREGoRi Data Coordination and Outreach Center, aimed at advancing the Genomics Research to Elucidate the Genetics of Rare Disease (GREGoR) program. This initiative seeks to enhance the diagnosis of rare genetic disorders by developing innovative tools and analytical methods to identify causal genes and variants, with the center serving as the primary coordination hub for data and resources generated by the GREGoRi program. The total estimated funding for this cooperative agreement is $2 million, with one award anticipated, and applications are expected to be due in 2026 following the publication of the Notice of Funding Opportunity (NOFO) in 2025. For further inquiries, interested applicants can contact Lisa H. Chadwick at lisa.chadwick@nih.gov or by phone at 301-435-7275.
    GREGoRi Innovation Projects (U01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is set to announce a funding opportunity titled "GREGoRi Innovation Projects (U01 Clinical Trial Optional)" aimed at soliciting applications for research on proof of concept studies that explore innovative strategies for identifying genes or variants associated with rare genetic disorders. This initiative seeks to advance beyond traditional DNA sequencing methods by incorporating emerging molecular technologies, such as multi-omics and RNA-seq, to enhance the understanding of these disorders. The funding will be provided through a cooperative agreement, with no cost-sharing requirement, and is particularly targeted at small businesses engaged in health-related research. Interested applicants should prepare for the anticipated Notice of Funding Opportunity (NOFO) publication in 2025, with applications due in 2026, and can reach out to Lisa H. Chadwick at lisa.chadwick@nih.gov or by phone at 301-435-7275 for further information.
    GREGoRi Technology Integration Center (U01, Clinical Trials Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is announcing a funding opportunity for the establishment of the GREGoRi Technology Integration Center (TechIC) under the Genomics Research to Elucidate the Genetics of Rare Disease (GREGoR) program. This initiative aims to advance the diagnosis of rare genetic disorders by developing standards and best practices for new molecular methods, ultimately producing a multidimensional dataset to support the creation and evaluation of innovative diagnostic tools. The total estimated funding for this cooperative agreement is $3 million, with one award anticipated, and applications are expected to be due in 2026 following the publication of the Notice of Funding Opportunity (NOFO) in 2025. For further inquiries, interested applicants can contact Lisa H. Chadwick at lisa.chadwick@nih.gov or by phone at 301-435-7275.
    Notice of Intent to Publish a Forecast for EmbraceHealth Clinical Research Network to Reduce Health Disparities – Research Sites
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) for the EmbraceHealth Clinical Research Network, aimed at reducing health disparities through collaborative research initiatives. This opportunity seeks to establish a network of research sites that will develop, test, and implement clinical and behavioral interventions addressing urgent health needs among populations experiencing health disparities. The initiative emphasizes the importance of creating a robust infrastructure for research, including efficient clinician recruitment, harmonization of electronic health record data, and collaboration among network sites to facilitate comprehensive health research. Interested applicants can reach out to Dr. Larissa Avilés-Santa at avilessantal@nih.gov or by phone at 301-827-6924 for further information. The estimated synopsis post date is November 28, 2025, with applications expected to be solicited by February 2, 2026, and project start dates anticipated for September 1, 2026.
    Genomic Variant Interactions With Other Variants Or The Environment (UM1 Clinical Trials Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is announcing a funding opportunity titled "Genomic Variant Interactions With Other Variants Or The Environment," aimed at studying the effects of genetic and environmental interactions on genomic variant impact. This initiative seeks to establish research frameworks that will experimentally test combinations of variants to identify significant interactions that could enhance the understanding of Genome-wide Association Studies (GWAS) and improve polygenic scores. The total estimated funding for this program is $10 million, with approximately five awards expected to be made. Interested applicants, including small businesses and eligible foreign entities, should prepare for the anticipated Notice of Funding Opportunity (NOFO) publication in 2025, with applications due later that year. For further inquiries, contact Mike Pazin at michael.pazin@nih.gov or by phone at 301-480-2629.
    Limited Competition: Building Partnerships and Broadening Perspectives to Advance Ethical, Legal, and Social Implications (ELSI) Research (BBAER) Program (UM1), Clinical Trial Optional
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Limited Competition: Building Partnerships and Broadening Perspectives to Advance Ethical, Legal, and Social Implications (ELSI) Research (BBAER) Program," aimed at fostering transdisciplinary ELSI research among underrepresented domestic organizations. The program seeks applications from entities that have received less than $30 million in NIH funding annually over the past three years, focusing on enhancing community engagement, building research capacity, and developing a diverse workforce in the field of genomics. With an anticipated funding amount of approximately $4.8 million for up to four awards, projects can last up to five years, and applicants must adhere to specific guidelines and deadlines, with submissions due by August 2, 2026. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov.
    Notice of Intent to Publish a Funding Opportunity Announcement for ClinGen Genomic Curation Expert Panels
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) for the establishment and continuation of Genomic Curation Expert Panels under the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). The objective of this funding opportunity is to solicit applications from small businesses to manually curate, review, and define the clinical relevance of genes and variants, addressing the challenge of genomic variants with unknown significance that hinder advancements in genomic and precision medicine. This initiative is crucial for enhancing the understanding of the links between genes, variants, and diseases, ultimately contributing to a centralized public resource for expert-curated genetic data. The estimated total program funding is $880,000, with four expected awards, and interested applicants can contact Dr. Julia Jiaqi O'Reilly at Jiaqi.OReilly@nih.gov or 240-328-8649 for further information. Key deadlines include an estimated synopsis post date of March 25, 2026, and a close date of May 25, 2026, with awards anticipated by April 1, 2027.